Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕Aditya Birla Sun Life International Equity Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundAditya Birla Sun Life International Equity Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaABSL
NAV₹666.3420₹51.5682
NAV date20 Nov 202619 Nov 2026
History13.9 years13.9 years
Expense ratio1.0%2.0%
Stars★★★★★★★★★★
Growth Score75.2076.60

Returns

Nippon India Pharma FundAditya Birla Sun Life International Equity Fund
1 month+11.40%−8.53%
3 months+3.74%−10.42%
6 months+8.55%−8.42%
YTD+16.94%+2.22%
1 year+15.26%+8.04%
3 years (CAGR)+17.96%+17.05%
5 years (CAGR)+15.40%+9.76%
10 years (CAGR)+16.61%+12.23%
Since launch+17.63%+11.13%

Risk

Nippon India Pharma FundAditya Birla Sun Life International Equity Fund
Volatility14.1%13.1%
Downside volatility9.0%7.7%
Sharpe0.810.81
Sortino1.281.36
Calmar1.221.23
Return / risk1.271.31
Deepest fall−24.02%−27.46%
Days to recover44577
Below its high+0.00%−12.20%

Against benchmark

Nippon India Pharma FundAditya Birla Sun Life International Equity Fund
Alpha−1.86%+9.53%
Beta0.890.08
R²89.5%1.0%
Up capture85.2%42.7%
Down capture88.7%−27.4%
Tracking error4.8%19.7%
Information ratio−0.690.23
Treynor0.121.22

Consistency

Nippon India Pharma FundAditya Birla Sun Life International Equity Fund
Best 1-year+90.70%+57.49%
Middle 1-year+13.13%+11.36%
Worst 1-year−15.12%−15.10%
1-year periods with a loss23.2%15.1%
Middle 3-year+19.82%+10.25%
Positive months63.9%66.7%
Best day+3.40%+2.91%
Worst day−3.21%−4.85%
Worst 5% day−1.38%−1.21%
Positive days53.7%57.7%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundAditya Birla Sun Life International Equity Fund
5-year XIRR+18.24%+13.10%
5-year value₹9,54,076₹8,38,608
3-year XIRR+14.26%+13.46%
1-year XIRR+22.08%−6.28%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth